韩国2011 - 2020年国家药品支出趋势
Yujeong Kim1, Jungmi Chae1, Seohee Shin1
1Health Insurance Review and Assessment (HIRA) Research Institute, Wonju, Korea.
Infection & chemotherapy
|July 5, 2023
概括
韩国的制药支出在2011-2020年间大幅增长,尽管其在总卫生支出中的份额下降. 这一趋势凸显了需要有效的药品支出管理策略的需要.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 公共卫生 公共卫生
背景情况:
- 分析药品支出 (PE) 趋势及其在整体卫生支出 (HE) 中的份额对于医疗保健系统管理至关重要.
- 与国际基准 (经济合作与发展组织 - OECD) 相比,了解国家制药支出模式提供了宝贵的见解.
- 本研究侧重于韩国10年 (2011-2020年) 的研究,以评估制药支出动态.
研究的目的:
- 确定2011年至2020年韩国医药支出 (PE) 的趋势及其在卫生支出 (HE) 中的比例.
- 分析不同药理学组 (解剖治疗化学品 - ATC 1 级分类) 的支出模式.
- 将韩国药品支出数据与其他经合组织国家进行比较,并得出对药品管理的政策影响.
主要方法:
- 利用经合组织卫生统计数据和韩国国家医疗保险索赔数据库 (HIRA) 2011-2020年期间.
- 检查了国家卫生支出 (HE),药品支出 (PE) 和按ATC1级分类的药品销售数据.
- 补充了经合组织的有限的ATC1级数据与特定类别 (D,L,P,S) 的HIRA索赔数据.
主要成果:
- 韩国制药支出 (PE) 在2011年至2020年期间增长了38.5% (19.9亿美元至276亿美元).
- 在同一时期,PE在总卫生支出中的份额下降了6.3个百分点,从26.4%降至20.1%.
- 2020年,韩国在人均PE (760.9美元PPP) 排名第三,在19个经合组织国家中拥有最高的PE份额 (20.1%) . 在ATC组A (食道和新陈代谢) 的支出最高,在L组 (抗菌素和免疫调节剂) 的支出增长最大.
结论:
- 韩国制药支出 (PE) 的持续增长需要宏观的管理策略.
- 根据ATC代码对PE的分析为卫生当局提供了有价值的数据,以制定未来的制药支出政策.
- 这些发现强调了持续监测和战略规划对国家医疗保健系统内的药品资源分配的重要性.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
156
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
156
Prescription, Nonprescription and Orphan Drugs
780
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
780
Pharmacokinetic Models: Overview
809
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
809
Drug Control Governance: Regulatory Bodies and Their Impact
190
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
190
Drug Administration and Therapy Phases: Overview
557
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
557


